Challenges and Solutions for Collecting and Analyzing Real World Data: The Eric CLL Database as an Illustrative Example.
作者信息
Chatzidimitriou Anastasia, Minga Eva, Chatzikonstantinou Thomas, Moreno Carol, Stamatopoulos Kostas, Ghia Paolo
机构信息
Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
出版信息
Hemasphere. 2020 Sep 30;4(5):e425. doi: 10.1097/HS9.0000000000000425. eCollection 2020 Oct.
Abstract
摘要
相似文献
1
Challenges and Solutions for Collecting and Analyzing Real World Data: The Eric CLL Database as an Illustrative Example.收集和分析真实世界数据的挑战与解决方案：以埃里克慢性淋巴细胞白血病数据库为例
Hemasphere. 2020 Sep 30;4(5):e425. doi: 10.1097/HS9.0000000000000425. eCollection 2020 Oct.
2
Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece.在希腊的一家单中心，对 58 例接受伊布替尼单药治疗的 CLL 患者的长期真实世界数据进行安全性和疗效分析。
Leuk Lymphoma. 2019 Dec;60(12):2939-2945. doi: 10.1080/10428194.2019.1620944. Epub 2019 Jun 11.
3
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.RESONATE-2™ 和 RESONATE™ 研究中单药伊布替尼与真实世界 PHEDRA 数据库中治疗慢性淋巴细胞白血病患者的治疗方案相比。
Ann Hematol. 2019 Dec;98(12):2749-2760. doi: 10.1007/s00277-019-03830-8. Epub 2019 Nov 19.
4
Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations.慢性淋巴细胞白血病的多学科诊断：欧洲慢性淋巴细胞白血病研究倡议（ERIC）建议
Hematol Transfus Cell Ther. 2020 Jul-Sep;42(3):269-274. doi: 10.1016/j.htct.2019.07.006. Epub 2019 Sep 11.
5
Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature.靶向治疗时代黑色素瘤与慢性淋巴细胞白血病共存的临床思考，由罕见临床病例引发。病例系列及文献综述
Ther Adv Med Oncol. 2020 Oct 5;12:1758835920962369. doi: 10.1177/1758835920962369. eCollection 2020.
6
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.通过流式细胞术实现慢性淋巴细胞白血病的可重现诊断：欧洲慢性淋巴细胞白血病研究倡议（ERIC）和欧洲临床细胞分析学会（ESCCA）的一项协调项目。
Cytometry B Clin Cytom. 2018 Jan;94(1):121-128. doi: 10.1002/cyto.b.21595. Epub 2018 Jan 17.
7
The real world: CLL.真实世界：CLL。
Blood. 2011 Mar 31;117(13):3481-2. doi: 10.1182/blood-2011-01-328625.
8
Specifying and comparing implementation strategies across seven large implementation interventions: a practical application of theory.在七个大型实施干预措施中指定和比较实施策略：理论的实际应用。
Implement Sci. 2019 Mar 21;14(1):32. doi: 10.1186/s13012-019-0876-4.
9
Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases.免疫球蛋白序列分析和 CLL 预后：ERIC 审查委员会关于可靠解读疑难病例的指南。
Leukemia. 2011 Jun;25(6):979-84. doi: 10.1038/leu.2011.49. Epub 2011 Apr 1.
10
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.多参数流式细胞术和高通量测序在慢性淋巴细胞白血病微小残留病检测中的互补作用：一项欧洲慢性淋巴细胞白血病研究倡议。
Leukemia. 2016 Apr;30(4):929-36. doi: 10.1038/leu.2015.313. Epub 2015 Dec 7.
引用本文的文献
1
Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities.在慢性淋巴细胞白血病中实现精准医学：尚存的挑战与潜在机遇。
Hemasphere. 2024 Jul 21;8(7):e113. doi: 10.1002/hem3.113. eCollection 2024 Jul.
2
Trends in Population-Based Studies: Molecular and Digital Epidemiology (Review).基于人群的研究趋势：分子和数字流行病学（综述）。
Sovrem Tekhnologii Med. 2022;14(4):60-70. doi: 10.17691/stm2022.14.4.07. Epub 2022 Jul 29.
3
Clinical Source Data Production and Quality Control in Real-world Studies: Proposal for Development of the eSource Record System.真实世界研究中的临床源数据生成与质量控制：电子源记录系统开发提案
JMIR Res Protoc. 2022 Dec 23;11(12):e42754. doi: 10.2196/42754.
本文引用的文献
1
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.在临床试验之外，采用奥滨尤妥珠单抗联合苯丁酸氮芥进行慢性淋巴细胞白血病的一线治疗：ERIC 和以色列 CLL 研究组的一项多中心跨国研究结果。
Am J Hematol. 2020 Jun;95(6):604-611. doi: 10.1002/ajh.25766. Epub 2020 Mar 14.
2
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.iwCLL 指南：用于 CLL 的诊断、治疗指征、疗效评估和支持性管理。
Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.
3
Real-world Data for Clinical Evidence Generation in Oncology.真实世界数据在肿瘤学临床证据生成中的应用。
J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx187.
4
Clinical Data Reuse or Secondary Use: Current Status and Potential Future Progress.临床数据的再利用或二次使用：现状与未来潜在进展
Yearb Med Inform. 2017 Aug;26(1):38-52. doi: 10.15265/IY-2017-007. Epub 2017 Sep 11.
5
The Effect of the General Data Protection Regulation on Medical Research.《通用数据保护条例》对医学研究的影响
J Med Internet Res. 2017 Feb 24;19(2):e47. doi: 10.2196/jmir.7108.
6
Chronic lymphocytic leukaemia.慢性淋巴细胞白血病
Nat Rev Dis Primers. 2017 Feb 9;3:17008. doi: 10.1038/nrdp.2017.8.
7
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.定型B细胞受体免疫球蛋白在慢性淋巴细胞白血病中的临床疗效：一项回顾性多中心研究
Lancet Haematol. 2014 Nov;1(2):e74-84. doi: 10.1016/S2352-3026(14)00005-2. Epub 2014 Nov 3.
8
The FAIR Guiding Principles for scientific data management and stewardship.科学数据管理和保存的 FAIR 指导原则。
Sci Data. 2016 Mar 15;3:160018. doi: 10.1038/sdata.2016.18.
9
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.反复出现的突变可改善慢性淋巴细胞白血病的预后。
Leukemia. 2015 Feb;29(2):329-36. doi: 10.1038/leu.2014.196. Epub 2014 Jun 19.
10
Strategies for de-identification and anonymization of electronic health record data for use in multicenter research studies.用于多中心研究的电子健康记录数据去识别和匿名化策略。
Med Care. 2012 Jul;50 Suppl(Suppl):S82-101. doi: 10.1097/MLR.0b013e3182585355.
Zotero 插件